The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland

Fondazione Epatocentro Ticino501 enrolled

Overview

PBC is a rare, autoimmune, cholestatic liver disease with genetic and environmental pathogenetic factors. Data about epidemiology of PBC in Switzerland are completely lacking. Epidemiology can be a powerful tool in yielding important clues as to burden and etiology of diseases. In addition, the investigators study will be the first one carried out in the country on PBC, and therefore will raise disease awareness and create a network.

Study Type

OBSERVATIONAL

Enrollment

501

Conditions

Primary Biliary Cirrhosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * PBC patients living in Switzerland Exclusion Criteria: \-

Locations (1)

Fondazione Epatocentro Ticino

Lugano, Switzerland

Outcomes

Primary Outcomes

Prevalence of PBC in Switzerland

Time frame: from 1.1.2005 until 31.12.2015

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.